1. Technetium-99m-MIBI and thallium-201 scintigraphy of primary lung cancer;Nishiyama;J Nucl Med,1997
2. Imaging multidrug resistance with radiolabeled substrates for P-glycoprotein and multidrug resistance protein;Ballinger;Cancer Biother Radiopharm,2001
3. Scintigraphic detection of multidrug resistance in cancer;Del Vecchio;Cancer Biother Radiopharm,2000
4. Role of thallium-201 chloride and Tc-99m methoxy-isobutyl-isonitrile (sestaMIBI) in evaluation of breast masses: correlation with the immunohistochemical characteristic parameters (Ki-67, PCNA, Bcl, and angiogenesis) in malignant lesions;Omar;Anticancer Res,1997
5. Monitoring response to therapy with thallium-201 and technetium-99m-sestamibi SPECT in nasopharyngeal carcinoma;Kostakoglu;J Nucl Med,1997